Assistant Professor of Pediatrics, Johns Hopkins University School of Medicine
Pediatric Endocrinology
Dr. Scott M. Blackman, MD
|
|
Give Review
Scott M. Blackman practices Pediatric Endocrinology. He researched medicine at Vanderbilt University School of Medicine. He has 2 awards "Top Doctors:Baltimore Area" and "Top Doctors:Washington-Baltimore". Scott Blackman is a published doctor and has 19 publications published. The lastest was: 'Self-reported exercise and longitudinal outcomes in cystic fibrosis: a retrospective cohort study.'
Publications
- Insulin pump use in young children in the T1D Exchange clinic registry is associated with lower hemoglobin A1c levels than injection therapy.
- Genetic modifiers of cystic fibrosis-related diabetes.
- Variation in MSRA Modifies Risk of Neonatal Intestinal Obstruction in Cystic Fibrosis.
- Genome-wide association and linkage identify modifier loci of lung Disease severity in cystic fibrosis at 11p13 and 20q13.2.
- A novel lung Disease phenotype adjusted for mortality attrition for cystic fibrosis Genetic modifier studies.
- Quantification of the relative contribution of environmental and genetic factors to variation in cystic fibrosis lung function.
- Genetic modifiers play a substantial role in diabetes complicating cystic fibrosis.
- Interactions between secondhand smoke and genes that affect cystic fibrosis lung Disease.
- Heritability of lung Disease severity in cystic fibrosis.
- Relative contribution of genetic and nongenetic modifiers to intestinal obstruction in cystic fibrosis.
- The PDZ1 domain of SAP90. Characterization of structure and binding.
- Self-reported exercise and longitudinal outcomes in cystic fibrosis: a retrospective cohort study.
- Modifier gene study of meconium ileus in cystic fibrosis: statistical considerations and gene mapping results.
- Understanding the population structure of North American patients with cystic fibrosis.
- A susceptibility gene for type 2 diabetes confers substantial risk for diabetes complicating cystic fibrosis.
- Interaction between a novel TGFB1 haplotype and CFTR genotype is associated with improved lung function in cystic fibrosis.
- Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients.
- Use of a modeling framework to evaluate the effect of a modifier gene (MBL2) on variation in cystic fibrosis.
Schools
Vanderbilt University
Conditions Treated
- Adrenogenital Disorders
- Hashimoto's Disease
- Hypothyroidism
- Thyroiditis
Doctors Specialties
- Pediatric Endocrinology
Accepted Insurances
Awards
- Top Doctors:Baltimore Area
- Top Doctors:Washington-Baltimore
Education
-
Johns Hopkins University -
Vanderbilt University School of Medicine
Hospital
-
Johns Hopkins Hospital
Helpful Reviews
Similar Doctors
|
Dr. Ryan Miller, MD |
|
|
Dr. Berrin Ergun-Longmire, MD |
|
|
Dr. Judith V. McLaughlin, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sally Radovick, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Dominique N. Long, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher J. Romero, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniela I. Sima, MD |
|
|
Dr. Emily L. Germain-Lee, MD |
|
|
Dr. Kristin M. Arcara, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ines Guttmann-Bauman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Claude J. Migeon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarah Orton, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Sara A. Divall, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|